Showing results (1-10 of 1,778) with videos related to
Sort By:
Pageof 178
International Journal of General Medicine|March 28, 2022
Epigenetic Modifications in the Pathogenesis of Systemic SclerosisJiangfan Yu, Rui Tang, Ke DingBiomed Research International|May 24, 2022
Recommendations for the Management of Patients with Benign Prostatic Hyperplasia in the Context of the COVID-19 Pandemic: A Retrospective Study of 314 CasesKe Ding, Rui Tang, JiangFan YuScientific Reports|August 9, 2022
Analysis of related factors between the occurrence of secondary epidermoid cyst of penis and circumcisionJiangFan Yu, Rui Tang, Ke DingFrontiers in Oncology|October 17, 2022
Identification of pyroptosis-related lncRNA signature and AC005253.1 as a pyroptosis-related oncogene in prostate cancerJiangFan Yu, Rui Tang, JinYu LiJournal of Neuro-Oncology|March 5, 2024
Immunological signatures and predictive biomarkers for first-generation somatostatin receptor ligand resistance in AcromegalyMei Luo, Jiangfan Yu, Rui TangPharmacological Research|September 3, 2020
The aryl hydrocarbon receptor: An environmental effector in the pathogenesis of fibrosisYaqian Shi, Zhuotong Zeng, Jiangfan Yu, et al.Nanomaterials (Basel, Switzerland)|May 27, 2023
Biodegradable Microrobots and Their Biomedical Applications: A ReviewJinxin Li, Jiangfan YuInternational Immunopharmacology|March 16, 2020
Safety and efficacy of Rituximab in systemic sclerosis: A systematic review and meta-analysisRui Tang, Jiangfan Yu, Yaqian Shi, et al.Pharmacological Research|January 7, 2022
Esomeprazole alleviates fibrosis in systemic sclerosis by modulating AhR/Smad2/3 signalingJiani Liu, Zixin Pi, Yangfan Xiao, et al.International Immunopharmacology|January 27, 2023
UVA1 irradiation attenuates collagen production via Ficz/AhR/MAPK signaling activation in sclerodermaYaqian Shi, Yangfan Xiao, Jiangfan Yu, et al.Pageof 178